speb/financial-data huggingface dataset:
Financial ratios for FML.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 59395031.05590062
Buffett classification: The Gruesome
Stock price: 0.10559006211180125
Shares outstanding: 286558645
Book value: 59395031.0559006
P/B ratio: 0.5094322637148895
Market cap (USD): 30257745.124223605
Debt to equity: 1.6746177817748316
Current ratio: 0.3420486065910297
Quick ratio: 0.27429578522575926
Buyback yield (%): 0
Retained earnings: -217586956.52173913
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FND — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 130.01
Shares outstanding: 108094150
Market cap (USD): 14053320441.499998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FND — annual report dated 2022-12-31
Total revenue: 4264473000
Gross profit: 1727716000
Operating income: 435402000
Net income: 298195000
Capital expenditures: 451827000
Operating cash flow: 112450000
Depreciation & amortization: 155023000
Net tangible assets: 1249350000
Owner earnings: 1391000
Return on net tangible assets (%): 0.111337895705767
Capex to operating income (%): 103.77237587333086
Buffett classification: The Gruesome
Stock price: 69.63
P/E ratio: 25.240515986183535
Shares outstanding: 108094150
Book value: 1657176000
P/B ratio: 4.541820340446639
Market cap (USD): 7526595664.499999
Debt to equity: 1.0504943349408873
Current ratio: 1.4477014337109813
Quick ratio: 0.1640404148762662
Effective tax rate (%): 22.671683669500183
Interest coverage ratio: 39.091578380319625
COGS to revenue (%): 59.48582626739576
SG&A to revenue (%): 30.30418999018167
Free cash flow (dilution-adjusted): -366383000
Buyback yield (%): 0
Retained earnings: 1170421000
Inventory turnover: 1.9629237288135593
Receivables turnover: 41.78520826596902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.018510478746498
FCF margin (%): -8.591518811351367
Rule of 40 score: -8.591518811351367
Financial ratios for FND — annual report dated 2023-12-31
Total revenue: 4413884000
Gross profit: 1858348000
Operating income: 321428000
Net income: 245980000
Capital expenditures: 547613000
Operating cash flow: 803589000
Depreciation & amortization: 201869000
Net tangible assets: 1519181000
Owner earnings: -99764000
Return on net tangible assets (%): -6.566959434063485
Capex to operating income (%): 170.3687917667409
Buffett classification: The Gruesome
Stock price: 111.56
P/E ratio: 49.024243328725916
Shares outstanding: 108094150
Book value: 1930990000
P/B ratio: 6.244974533270499
Market cap (USD): 12058983374
Debt to equity: 0.8416532452265418
Current ratio: 1.1429037693151032
Quick ratio: 0.18271495200140972
Effective tax rate (%): 21.04156568688188
Interest coverage ratio: 19.732825833384492
COGS to revenue (%): 57.89767016985494
SG&A to revenue (%): 34.820126673016325
Free cash flow (dilution-adjusted): 228736000
Buyback yield (%): 0
Retained earnings: 1416401000
Inventory turnover: 2.310297880034353
Receivables turnover: 34.650494964006185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.156092073662805
FCF margin (%): 5.182193279207156
Revenue growth (%): 3.503621666733498
Rule of 40 score: 8.685814945940654
Financial ratios for FND — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 124.17
Shares outstanding: 108094150
Market cap (USD): 13422050605.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FND — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 99.7
Shares outstanding: 108094150
Market cap (USD): 10776986755
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FND — annual report dated 2024-12-31
Total revenue: 4455770000
Gross profit: 1928251000
Operating income: 256176000
Net income: 205872000
Capital expenditures: 446826000
Operating cash flow: 603155000
Depreciation & amortization: 232473000
Net tangible assets: 1762015000
Owner earnings: -8481000
Return on net tangible assets (%): -0.48132393878599217
Capex to operating income (%): 174.4214914746112
Buffett classification: The Gruesome
Stock price: 99.7
P/E ratio: 52.34799659497163
Shares outstanding: 108094150
Book value: 2170158000
P/B ratio: 4.965991764194127
Market cap (USD): 10776986755
Debt to equity: 0.7771590824262565
Current ratio: 1.199481269771868
Quick ratio: 0.2891724106890255
Effective tax rate (%): 18.75707864547776
Interest coverage ratio: 24.837696335078533
COGS to revenue (%): 56.72462896424187
SG&A to revenue (%): 37.52606171323924
Free cash flow (dilution-adjusted): 122634000
Buyback yield (%): 0
Retained earnings: 1622273000
Inventory turnover: 2.231609775392703
Receivables turnover: 36.160800512899584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.730340284466275
FCF margin (%): 2.7522515749241996
Revenue growth (%): 0.948960144852017
Rule of 40 score: 3.7012117197762167
Financial ratios for FND — quarterly report dated 2025-03-31
Total revenue: 1160740000
Gross profit: 508168000
Operating income: 64229000
Net income: 48878000
Capital expenditures: 66728000
Operating cash flow: 71164000
Depreciation & amortization: 59965000
Net tangible assets: 1814537000
Owner earnings: 42115000
Return on net tangible assets (%): 2.3209777480426137
Capex to operating income (%): 103.8907658534307
Buffett classification: The Gruesome
Stock price: 80.47
P/E ratio: 44.49003769845329
Shares outstanding: 108094150
Book value: 2221763000
P/B ratio: 3.915060359948383
Market cap (USD): 8698336250.5
Debt to equity: 0.8792413952343252
Current ratio: 1.2217735244562442
Quick ratio: 0.27297878586745633
Effective tax rate (%): 22.021027105502462
Interest coverage ratio: 20.540134314039015
COGS to revenue (%): 56.220342195495974
SG&A to revenue (%): 38.246205007150614
Free cash flow (dilution-adjusted): -2144000
Buyback yield (%): 0
Retained earnings: 1671151000
Inventory turnover: 0.5486942937044592
Receivables turnover: 11.00217059553938
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5609415859005142
FCF margin (%): -0.18470975412237023
Rule of 40 score: -0.18470975412237023
Financial ratios for FND — quarterly report dated 2025-06-30
Total revenue: 1214150000
Gross profit: 532688000
Operating income: 87018000
Net income: 63178000
Capital expenditures: 94099000
Operating cash flow: 84112000
Depreciation & amortization: 59988000
Net tangible assets: 1888033000
Owner earnings: 29067000
Return on net tangible assets (%): 1.539538768654997
Capex to operating income (%): 108.13739686041967
Buffett classification: The Gruesome
Stock price: 75.96
P/E ratio: 73.27435955236668
Shares outstanding: 108094150
Book value: 2294342000
P/B ratio: 3.5787304743582253
Market cap (USD): 8210831633.999999
Debt to equity: 0.8507188553406597
Current ratio: 1.254797092538987
Quick ratio: 0.276085187929044
Effective tax rate (%): 21.826820757751985
Interest coverage ratio: 80.87174721189591
COGS to revenue (%): 56.12667298109789
SG&A to revenue (%): 36.70633776716221
Free cash flow (dilution-adjusted): -18909000
Buyback yield (%): 0
Retained earnings: 1734329000
Inventory turnover: 0.5625264666332627
Receivables turnover: 10.760783827139704
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0850295653540725
FCF margin (%): -1.557385825474612
Revenue growth (%): 4.60137498492341
Rule of 40 score: 3.043989159448798
Financial ratios for FND — quarterly report dated 2025-09-30
Total revenue: 1179527000
Gross profit: 511956000
Operating income: 80646000
Net income: 57260000
Capital expenditures: 78012000
Operating cash flow: 102492000
Depreciation & amortization: 60539000
Net tangible assets: 1956757000
Owner earnings: 39787000
Return on net tangible assets (%): 2.0333132831516636
Capex to operating income (%): 96.73387396771074
Buffett classification: The Gruesome
Stock price: 73.7
P/E ratio: 47.05130557655508
Shares outstanding: 108094150
Book value: 2362150000
P/B ratio: 3.3725795800436043
Market cap (USD): 7966538855
Debt to equity: 0.8404885379844633
Current ratio: 1.2701183354167314
Quick ratio: 0.3426189946947045
Effective tax rate (%): 19.833113992103716
Interest coverage ratio: 136.45685279187816
COGS to revenue (%): 56.59650012250673
SG&A to revenue (%): 36.56635244466638
Free cash flow (dilution-adjusted): 17610000
Buyback yield (%): 0
Retained earnings: 1791589000
Inventory turnover: 0.5734352894487962
Receivables turnover: 6.953692240576327
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.890615937663078
FCF margin (%): 1.4929713351199252
Revenue growth (%): -2.8516245933369024
Rule of 40 score: -1.3586532582169772
Financial ratios for FND — quarterly report dated 2025-12-31
Total revenue: 1129671000
Gross profit: 491096000
Operating income: 32184000
Net income: 39331000
Capital expenditures: 78925000
Operating cash flow: 124068000
Depreciation & amortization: 60668000
Net tangible assets: 2004360000
Owner earnings: 21074000
Return on net tangible assets (%): 1.05140793071105
Capex to operating income (%): 245.2305493412876
Buffett classification: The Gruesome
Stock price: 60.89
P/E ratio: 31.54539865658265
Shares outstanding: 108094150
Book value: 2408836000
P/B ratio: 2.7323789554373983
Market cap (USD): 6581852793.5
Debt to equity: 0.826738308461016
Current ratio: 1.3270316747583355
Quick ratio: 0.3429315870382755
Effective tax rate (%): 23.977501159734036
Interest coverage ratio: 3.9970193740685542
COGS to revenue (%): 56.52751995935099
SG&A to revenue (%): 40.6235089685404
Free cash flow (dilution-adjusted): 38010000
Buyback yield (%): 0
Retained earnings: 1830920000
Inventory turnover: 0.5635730127448739
Receivables turnover: 11.147555704671495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7453505908334661
FCF margin (%): 3.3646964470186456
Revenue growth (%): -4.2267790393946045
Rule of 40 score: -0.862082592375959
Financial ratios for FND — annual report dated 2025-12-31
Total revenue: 4684088000
Gross profit: 2043908000
Operating income: 270070000
Net income: 208647000
Capital expenditures: 317764000
Operating cash flow: 381836000
Depreciation & amortization: 241160000
Net tangible assets: 2004360000
Owner earnings: 132043000
Return on net tangible assets (%): 6.587788620806642
Capex to operating income (%): 117.65986596067685
Buffett classification: The Gruesome
Stock price: 60.89
P/E ratio: 31.54539865658265
Shares outstanding: 108094150
Book value: 2408836000
P/B ratio: 2.7323789554373983
Market cap (USD): 6581852793.5
Debt to equity: 0.826738308461016
Current ratio: 1.3270316747583355
Quick ratio: 0.3429315870382755
Effective tax rate (%): 21.75571230888656
Interest coverage ratio: 23.970000887547705
COGS to revenue (%): 56.36486761136853
SG&A to revenue (%): 37.86944224788262
Free cash flow (dilution-adjusted): 34567000
Buyback yield (%): 0
Retained earnings: 1830920000
Inventory turnover: 2.3300852629507283
Receivables turnover: 46.2224239673173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.254562331170588
FCF margin (%): 0.7379664942247028
Revenue growth (%): 5.124097518498486
Rule of 40 score: 5.862064012723189
Financial ratios for FRAS3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 277335091
Market cap (USD): 582403691.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRAS3.SA — annual report dated 2022-12-31
Total revenue: 579199053.030303
Gross profit: 171113068.1818182
Operating income: 61885606.060606055
Net income: 38795075.75757576
Capital expenditures: 15934848.484848484
Operating cash flow: -19899810.606060605
Depreciation & amortization: 22742234.848484848
Net tangible assets: 244273295.45454544
Owner earnings: 45602462.121212125
Return on net tangible assets (%): 18.668623615346387
Capex to operating income (%): 25.748876837762737
Buffett classification: The Good
Stock price: 1.6622390891840608
P/E ratio: 11.88287998052425
Shares outstanding: 277335091
Book value: 336825378.78787875
P/B ratio: 1.3686534866273814
Market cap (USD): 460997229.0626186
Debt to equity: 0.6025073688259023
Current ratio: 2.6554540751583877
Quick ratio: 1.6606261729723963
Effective tax rate (%): 18.289590541751558
Interest coverage ratio: 2.917099648258253
COGS to revenue (%): 70.45694959503572
SG&A to revenue (%): 16.912657925276253
Free cash flow (dilution-adjusted): -35834659.090909086
Buyback yield (%): 0
Retained earnings: 111371590.9090909
Inventory turnover: 2.512273411475549
Receivables turnover: 11.256601565088083
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.252897115798536
FCF margin (%): -6.186933300982842
Rule of 40 score: -6.186933300982842
Financial ratios for FRAS3.SA — annual report dated 2023-12-31
Total revenue: 698692164.9484537
Gross profit: 234763092.78350517
Operating income: 106675670.10309279
Net income: 80150927.83505155
Capital expenditures: 27567010.309278354
Operating cash flow: 213920824.74226806
Depreciation & amortization: 25710309.278350517
Net tangible assets: 264664742.26804125
Owner earnings: 78294226.80412371
Return on net tangible assets (%): 29.582416657837495
Capex to operating income (%): 25.841890922866696
Buffett classification: The Good
Stock price: 3.312629399585921
P/E ratio: 11.462230080157198
Shares outstanding: 277335091
Book value: 383734845.3608248
P/B ratio: 2.3941228874317573
Market cap (USD): 918708375.9834368
Debt to equity: 0.5551057055075614
Current ratio: 2.1311125402622415
Quick ratio: 1.4298794782480604
Effective tax rate (%): 26.192275414766407
Interest coverage ratio: 4.7424881295029975
COGS to revenue (%): 66.3996385588745
SG&A to revenue (%): 17.05478010905205
Free cash flow (dilution-adjusted): 186353814.43298972
Buyback yield (%): 0
Retained earnings: 172614432.98969072
Inventory turnover: 2.882096987194841
Receivables turnover: 8.055648796165988
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.486511285884415
FCF margin (%): 26.671805378945113
Revenue growth (%): 20.63075056718004
Rule of 40 score: 47.30255594612515
Financial ratios for FRAS3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.5837937384898715
Shares outstanding: 277335091
Market cap (USD): 993911762.5893188
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRAS3.SA — annual report dated 2024-12-31
Total revenue: 641711326.8608415
Gross profit: 215292718.44660196
Operating income: 90743527.50809062
Net income: 60631553.39805826
Capital expenditures: 25868446.60194175
Operating cash flow: 18444012.94498382
Depreciation & amortization: 25681553.398058254
Net tangible assets: 264076213.59223303
Owner earnings: 60444660.19417477
Return on net tangible assets (%): 22.889096814872143
Capex to operating income (%): 28.507208516481068
Buffett classification: The Good
Stock price: 3.219709208400646
P/E ratio: 14.727287959175523
Shares outstanding: 277335091
Book value: 364317961.16504854
P/B ratio: 2.450986340200777
Market cap (USD): 892938346.3053311
Debt to equity: 0.5700419945058484
Current ratio: 2.053133664928206
Quick ratio: 1.352674959428876
Effective tax rate (%): 31.032026504693537
Interest coverage ratio: 4.302554856529078
COGS to revenue (%): 66.45022310891991
SG&A to revenue (%): 18.596158734129208
Free cash flow (dilution-adjusted): -8391423.948220065
Buyback yield (%): 0
Retained earnings: 166996601.94174758
Inventory turnover: 2.509441113145759
Receivables turnover: 9.145571780420086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.638850935869538
FCF margin (%): -1.30766336777468
Revenue growth (%): -8.155356671534443
Rule of 40 score: -9.463020039309123
Financial ratios for FRAS3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.219709208400646
Shares outstanding: 277335091
Market cap (USD): 892938346.3053311
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRAS3.SA — quarterly report dated 2025-03-31
Total revenue: 231201041.6666667
Gross profit: 79025868.05555555
Operating income: 31981944.444444444
Net income: 12147743.055555556
Capital expenditures: 3732291.666666667
Operating cash flow: 78775000
Depreciation & amortization: 9573437.5
Net tangible assets: 53709027.777777776
Owner earnings: 17988888.888888888
Return on net tangible assets (%): 33.493231274485716
Capex to operating income (%): 11.66999609154471
Buffett classification: The Great
Stock price: 4.572916666666667
P/E ratio: 26.100121110674422
Shares outstanding: 277335091
Book value: 375770659.7222222
P/B ratio: 3.3750113987689194
Market cap (USD): 1268230259.8854167
Debt to equity: 1.379331549653282
Current ratio: 2.187413040133581
Quick ratio: 1.074110286923434
Effective tax rate (%): 25.489841121097246
Interest coverage ratio: 2.3685151137225655
COGS to revenue (%): 65.8194152215409
SG&A to revenue (%): 19.48685832886542
Free cash flow (dilution-adjusted): 75042187.5
Buyback yield (%): 0
Retained earnings: 190963541.6666667
Inventory turnover: 0.5243888066286774
Receivables turnover: 2.0131365322578207
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.519677914391748
FCF margin (%): 32.45754731857645
Rule of 40 score: 32.45754731857645
Financial ratios for FRAS3.SA — quarterly report dated 2025-06-30
Total revenue: 248200729.9270073
Gross profit: 79564598.54014598
Operating income: 31003284.671532843
Net income: 9074452.554744525
Capital expenditures: 7807116.788321167
Operating cash flow: 47517518.24817518
Depreciation & amortization: 12507116.788321167
Net tangible assets: 62147262.773722626
Owner earnings: 13774452.554744527
Return on net tangible assets (%): 22.164214383660195
Capex to operating income (%): 25.18157953595687
Buffett classification: The Good
Stock price: 4.848540145985401
P/E ratio: 63.361508266910235
Shares outstanding: 277335091
Book value: 404929562.0437956
P/B ratio: 3.3207511840258785
Market cap (USD): 1344670322.6040146
Debt to equity: 1.3224152709266368
Current ratio: 2.2370349166777124
Quick ratio: 1.0683830766497362
Effective tax rate (%): 29.654411452660167
Interest coverage ratio: 0.9982960020683008
COGS to revenue (%): 67.94344699810313
SG&A to revenue (%): 18.615216080697575
Free cash flow (dilution-adjusted): 38655656.93430657
Buyback yield (%): 0
Retained earnings: 209926824.81751823
Inventory turnover: 0.5575235814196211
Receivables turnover: 2.3736054322047653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2555005961142776
FCF margin (%): 15.574352640169394
Revenue growth (%): 7.352773213214949
Rule of 40 score: 22.927125853384343
Financial ratios for FRAS3.SA — quarterly report dated 2025-09-30
Total revenue: 265802067.6691729
Gross profit: 89642293.2330827
Operating income: 39987781.95488722
Net income: 20216353.383458644
Capital expenditures: 9927443.609022556
Operating cash flow: 59545300.7518797
Depreciation & amortization: 10903383.458646616
Net tangible assets: 112825751.87969925
Owner earnings: 21192293.233082704
Return on net tangible assets (%): 18.783205855059617
Capex to operating income (%): 24.826192210966695
Buffett classification: The Great
Stock price: 4.172932330827067
P/E ratio: 27.928115144212068
Shares outstanding: 277335091
Book value: 457078195.4887217
P/B ratio: 2.531953129965752
Market cap (USD): 1157300567.7067668
Debt to equity: 1.212266044210201
Current ratio: 2.2681008956929434
Quick ratio: 1.2058769556522762
Effective tax rate (%): 3.1237896215963037
Interest coverage ratio: 1.2518757392619446
COGS to revenue (%): 66.27479461722818
SG&A to revenue (%): 17.92687333768485
Free cash flow (dilution-adjusted): 49617857.14285714
Buyback yield (%): 0
Retained earnings: 219178007.51879698
Inventory turnover: 0.5930539840682831
Receivables turnover: 2.358307302567831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9360157607148123
FCF margin (%): 18.667220152934764
Revenue growth (%): 7.091573722342378
Rule of 40 score: 25.758793875277142
Financial ratios for FRAS3.SA — annual report dated 2025-12-31
Total revenue: 1001985036.4963503
Gross profit: 327720985.4014598
Operating income: 127517700.729927
Net income: 51672627.73722627
Capital expenditures: 32382664.23357664
Operating cash flow: 279204744.52554744
Depreciation & amortization: 44892153.28467153
Net tangible assets: 106803649.63503648
Owner earnings: 64182116.78832115
Return on net tangible assets (%): 60.09356141633805
Capex to operating income (%): 25.3946425070514
Buffett classification: The Good
Stock price: 4.335727109515259
P/E ratio: 23.270526875146828
Shares outstanding: 277335091
Book value: 452825000
P/B ratio: 2.6554392369427076
Market cap (USD): 1202449272.4685814
Debt to equity: 1.2362415831513518
Current ratio: 2.4072879300656163
Quick ratio: 1.392870371544018
Effective tax rate (%): 11.757978416750547
Interest coverage ratio: 2.1544933774017707
COGS to revenue (%): 67.29282639315606
SG&A to revenue (%): 19.43432361819002
Free cash flow (dilution-adjusted): 244443613.13868612
Buyback yield (%): 0
Retained earnings: 144781751.8248175
Inventory turnover: 2.5649731907579616
Receivables turnover: 11.016104212935934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.042854685824562
FCF margin (%): 24.395934493536373
Revenue growth (%): 56.14264460593448
Rule of 40 score: 80.53857909947085
Financial ratios for FRAS3.SA — quarterly report dated 2025-12-31
Total revenue: 252728649.63503647
Gross profit: 78067700.729927
Operating income: 26300729.9270073
Net income: 10203649.635036496
Capital expenditures: 9959671.532846715
Operating cash flow: 91080474.45255473
Depreciation & amortization: 13177554.744525546
Net tangible assets: 106803649.63503648
Owner earnings: 13421532.846715327
Return on net tangible assets (%): 12.566548889086324
Capex to operating income (%): 37.86842251332149
Buffett classification: The Good
Stock price: 4.335727109515259
P/E ratio: 23.284238556762507
Shares outstanding: 277335091
Book value: 452825000
P/B ratio: 2.6554392369427076
Market cap (USD): 1202449272.4685814
Debt to equity: 1.2362415831513518
Current ratio: 2.4072879300656163
Quick ratio: 1.392870371544018
Effective tax rate (%): -23.492126592901787
Interest coverage ratio: 1.6998230923457958
COGS to revenue (%): 69.11007088327185
SG&A to revenue (%): 21.727379918307697
Free cash flow (dilution-adjusted): 78742335.76642334
Buyback yield (%): 0
Retained earnings: 144781751.8248175
Inventory turnover: 0.6644290922621113
Receivables turnover: 2.7785695799502848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.483858059148111
FCF margin (%): 31.156869583299933
Revenue growth (%): -4.918478681816766
Rule of 40 score: 26.238390901483168
Financial ratios for GCTS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.9
Shares outstanding: 90963011
Market cap (USD): 900533808.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCTS — annual report dated 2022-12-31
Total revenue: 16669000
Gross profit: 5053000
Operating income: -22753000
Net income: -26412000
Capital expenditures: 623000
Operating cash flow: -18087000
Depreciation & amortization: 1547000
Net tangible assets: -95601000
Owner earnings: -25488000
Buffett classification: The Gruesome
Stock price: 10.19
Shares outstanding: 90963011
Book value: -94929000
Market cap (USD): 926913082.0899999
Debt to equity: -0.7409432312570448
Current ratio: 0.15737552804434352
Quick ratio: 0.11488779820770151
Interest coverage ratio: -6.763674197384066
COGS to revenue (%): 69.68624392585038
R&D to revenue (%): 104.29539864418982
SG&A to revenue (%): 62.517247585338055
Free cash flow (dilution-adjusted): -19007000
Buyback yield (%): 0
Retained earnings: -527185000
Inventory turnover: 3.3379310344827586
Receivables turnover: 3.1221202472373104
Capitalized R&D asset: 17385000
FCF margin (%): -114.0260363549103
Rule of 40 score: -114.0260363549103
Financial ratios for GCTS — annual report dated 2023-12-31
Total revenue: 16028000
Gross profit: 6734000
Operating income: -14558000
Net income: -22469000
Capital expenditures: 331000
Operating cash flow: -8827000
Depreciation & amortization: 1790000
Net tangible assets: -115682000
Owner earnings: -21010000
Buffett classification: The Gruesome
Stock price: 10.56
Shares outstanding: 90963011
Book value: -115437000
Market cap (USD): 960569396.1600001
Debt to equity: -0.693642419674801
Current ratio: 0.11331782824191428
Quick ratio: 0.10037369012465049
Interest coverage ratio: -2.3307716938840857
COGS to revenue (%): 57.9860244571999
R&D to revenue (%): 66.83304217619165
SG&A to revenue (%): 66.00948340404292
Free cash flow (dilution-adjusted): -9201000
Buyback yield (%): 0
Retained earnings: -549654000
Inventory turnover: 6.2543741588156125
Receivables turnover: 1.8909863142991978
Capitalized R&D asset: 22359950
Rosenberg metric: 0.09669255104975553
FCF margin (%): -57.40578986773147
Revenue growth (%): -3.845461635371048
Rule of 40 score: -61.251251503102516
Financial ratios for GCTS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.35
Shares outstanding: 90963011
Market cap (USD): 304726086.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCTS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.33
Shares outstanding: 90963011
Market cap (USD): 211943815.63
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCTS — annual report dated 2024-12-31
Total revenue: 9128000
Gross profit: 5076000
Operating income: -26971000
Net income: -12379000
Capital expenditures: 542000
Operating cash flow: -30957000
Depreciation & amortization: 1325000
Net tangible assets: -59380000
Owner earnings: -11596000
Buffett classification: The Gruesome
Stock price: 2.33
Shares outstanding: 90963011
Book value: -59315000
Market cap (USD): 211943815.63
Debt to equity: -0.7324791368119363
Current ratio: 0.2887462657168182
Quick ratio: 0.23988050293818325
Interest coverage ratio: -6.974657357124386
COGS to revenue (%): 44.3908851884312
R&D to revenue (%): 189.8444347063979
SG&A to revenue (%): 161.2401402278703
Free cash flow (dilution-adjusted): -34199000
Buyback yield (%): 0
Retained earnings: -562033000
Inventory turnover: 1.3611017803157541
Receivables turnover: 0.8361271411559953
Capitalized R&D asset: 30243090
Rosenberg metric: -0.1547796863330844
FCF margin (%): -374.6603856266433
Revenue growth (%): -43.04966308959321
Rule of 40 score: -417.7100487162365
Financial ratios for GCTS — quarterly report dated 2025-03-31
Total revenue: 496000
Gross profit: 88000
Operating income: -7740000
Net income: -6968000
Capital expenditures: 118000
Operating cash flow: -7951000
Depreciation & amortization: 341000
Net tangible assets: -65658000
Owner earnings: -6745000
Buffett classification: The Gruesome
Stock price: 1.64
Shares outstanding: 90963011
Book value: -65626000
Market cap (USD): 149179338.04
Debt to equity: -0.7753786608965959
Current ratio: 0.21580074761644757
Quick ratio: 0.17206378540327888
Interest coverage ratio: -7.233644859813084
COGS to revenue (%): 82.25806451612904
R&D to revenue (%): 825.8064516129032
SG&A to revenue (%): 752.4193548387098
Free cash flow (dilution-adjusted): -8580000
Buyback yield (%): 0
Retained earnings: -569001000
Inventory turnover: 0.13060179257362356
Receivables turnover: 0.049123502030306035
Capitalized R&D asset: 4096000
FCF margin (%): -1729.8387096774193
Rule of 40 score: -1729.8387096774193
Financial ratios for GCTS — quarterly report dated 2025-06-30
Total revenue: 1182000
Gross profit: 378000
Operating income: -7592000
Net income: -13538000
Capital expenditures: 91000
Operating cash flow: -8638000
Depreciation & amortization: 339000
Net tangible assets: -69986000
Owner earnings: -13290000
Buffett classification: The Gruesome
Stock price: 1.49
Shares outstanding: 90963011
Book value: -69976000
Market cap (USD): 135534886.39
Debt to equity: -0.7489996570252658
Current ratio: 0.2126573388795851
Quick ratio: 0.17220841661714656
Interest coverage ratio: -4.955613577023499
COGS to revenue (%): 68.02030456852792
R&D to revenue (%): 297.2927241962775
SG&A to revenue (%): 376.98815566835873
Free cash flow (dilution-adjusted): -9241000
Buyback yield (%): 0
Retained earnings: -582539000
Inventory turnover: 0.2684474123539232
Receivables turnover: 0.11986613933678127
Capitalized R&D asset: 6258320
Rosenberg metric: 0.07080078125
FCF margin (%): -781.8104906937394
Revenue growth (%): 138.30645161290323
Rule of 40 score: -643.5040390808363
Financial ratios for GCTS — quarterly report dated 2025-09-30
Total revenue: 430000
Gross profit: -1050000
Operating income: -9254000
Net income: -13849000
Capital expenditures: 934000
Operating cash flow: -6863000
Depreciation & amortization: 346000
Net tangible assets: -80159000
Owner earnings: -14437000
Buffett classification: The Gruesome
Stock price: 1.52
Shares outstanding: 90963011
Book value: -80149000
Market cap (USD): 138263776.72
Debt to equity: -0.8126738948708031
Current ratio: 0.2510274365744461
Quick ratio: 0.22915853518539778
Interest coverage ratio: -5.190128996074033
COGS to revenue (%): 344.1860465116279
R&D to revenue (%): 757.6744186046511
SG&A to revenue (%): 1150.2325581395348
Free cash flow (dilution-adjusted): -9668000
Buyback yield (%): 0
Retained earnings: -596388000
Inventory turnover: 0.7769028871391076
Receivables turnover: 0.04586666666666667
Capitalized R&D asset: 6964060
Rosenberg metric: -0.4063745019920319
FCF margin (%): -2248.3720930232557
Revenue growth (%): -63.62098138747885
Rule of 40 score: -2311.9930744107346
Financial ratios for GCTS — quarterly report dated 2025-12-31
Total revenue: 758000
Gross profit: -1233000
Operating income: -11954000
Net income: -9017000
Capital expenditures: 1268000
Operating cash flow: -7223000
Depreciation & amortization: 425000
Net tangible assets: -83293000
Owner earnings: -9860000
Buffett classification: The Gruesome
Stock price: 1.2
Shares outstanding: 90963011
Book value: -83293000
Market cap (USD): 109155613.2
Debt to equity: -0.7607121846973935
Current ratio: 0.14932274520644334
Quick ratio: 0.1374236674792049
Interest coverage ratio: -7.284582571602681
COGS to revenue (%): 262.66490765171505
R&D to revenue (%): 413.8522427440633
SG&A to revenue (%): 1000.5277044854882
Free cash flow (dilution-adjusted): -11927000
Buyback yield (%): 0
Retained earnings: -605405000
Inventory turnover: 2.102428722280887
Receivables turnover: 0.09377706297166893
Capitalized R&D asset: 6479480
Rosenberg metric: -0.056169429097605895
FCF margin (%): -1573.4828496042217
Revenue growth (%): 76.27906976744187
Rule of 40 score: -1497.2037798367799
Financial ratios for GCTS — annual report dated 2025-12-31
Total revenue: 2866000
Gross profit: -1817000
Operating income: -36540000
Net income: -43372000
Capital expenditures: 2411000
Operating cash flow: -30675000
Depreciation & amortization: 1451000
Net tangible assets: -83293000
Owner earnings: -44332000
Buffett classification: The Gruesome
Stock price: 1.2
Shares outstanding: 90963011
Book value: -83293000
Market cap (USD): 109155613.2
Debt to equity: -0.7607121846973935
Current ratio: 0.14932274520644334
Quick ratio: 0.1374236674792049
Interest coverage ratio: -6.06372386325921
COGS to revenue (%): 163.39846475924634
R&D to revenue (%): 488.6601535240754
SG&A to revenue (%): 722.8890439637124
Free cash flow (dilution-adjusted): -39416000
Buyback yield (%): 0
Retained earnings: -605405000
Inventory turnover: 4.945089757127772
Receivables turnover: 0.35457132252876405
Capitalized R&D asset: 29150390
Rosenberg metric: -0.3977725200530902
FCF margin (%): -1375.2965806001396
Revenue growth (%): -68.60210341805434
Rule of 40 score: -1443.898684018194
Financial ratios for GESHIP.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.885665303969405
Shares outstanding: 142769679
Market cap (USD): 554755188.1491494
Buyback yield (%): 3.8780913020817334
Retained earnings: 377715943.5579586
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GESHIP.NS — annual report dated 2023-03-31
Total revenue: 689436053.5931791
Gross profit: 326589524.96954936
Operating income: 290475030.45066994
Net income: 313643118.14859927
Capital expenditures: 24214372.71619976
Operating cash flow: 362311814.85992694
Depreciation & amortization: 86729598.05115713
Net tangible assets: 1250861144.945189
Owner earnings: 376158343.4835566
Return on net tangible assets (%): 30.071950432199202
Capex to operating income (%): 8.336128815833613
Buffett classification: The Great
Stock price: 7.024116930572473
P/E ratio: 3.197363058229677
Shares outstanding: 142769679
Book value: 1251566382.460414
P/B ratio: 0.8012606710199935
Market cap (USD): 1002830919.4362972
Debt to equity: 0.3551593326170568
Current ratio: 4.521885006264792
Quick ratio: 4.379548934985383
Effective tax rate (%): -0.8407935650117092
Interest coverage ratio: 8.582739509105304
COGS to revenue (%): 52.629468205580295
SG&A to revenue (%): 1.2331567222058313
Free cash flow (dilution-adjusted): 305637028.0146164
Buyback yield (%): 0
Retained earnings: 558470158.3434836
Inventory turnover: 14.568515258215964
Receivables turnover: 16.782607406528896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.31564012976565
FCF margin (%): 44.33145415324711
Rule of 40 score: 44.33145415324711
Financial ratios for GESHIP.NS — annual report dated 2024-03-31
Total revenue: 620652356.3976496
Gross profit: 288150857.4169565
Operating income: 252638206.01990646
Net income: 313488427.8690491
Capital expenditures: 52196906.10384938
Operating cash flow: 336737018.8271975
Depreciation & amortization: 87069192.94879481
Net tangible assets: 1484851900.7075188
Owner earnings: 348360714.7139945
Return on net tangible assets (%): 23.460973754217758
Capex to operating income (%): 20.660733357066572
Buffett classification: The Great
Stock price: 11.24292226487524
P/E ratio: 5.120279602310221
Shares outstanding: 142769679
Book value: 1486683055.522245
P/B ratio: 1.0796843327270798
Market cap (USD): 1605148402.778191
Debt to equity: 0.24588120944226433
Current ratio: 5.4360002389660735
Quick ratio: 5.271790718823225
Effective tax rate (%): 2.976566037455741
Interest coverage ratio: 8.578670901539214
COGS to revenue (%): 53.57290527511679
SG&A to revenue (%): 1.547640669137224
Free cash flow (dilution-adjusted): 235381940.2806092
Buyback yield (%): 0
Retained earnings: 754923851.780789
Inventory turnover: 11.208383862883014
Receivables turnover: 16.185951963972983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.768374988644808
FCF margin (%): 37.924924936529344
Revenue growth (%): -9.976805946983038
Rule of 40 score: 27.948118989546305
Financial ratios for GESHIP.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1610348781.6531296
Buffett classification: The Gruesome
Stock price: 13.653368370759674
Shares outstanding: 142769679
Book value: 1612311275.680841
P/B ratio: 1.2090016667153642
Market cap (USD): 1949287019.5621116
Debt to equity: 0.2065412826977087
Current ratio: 5.420392415129976
Quick ratio: 5.240848203191013
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GESHIP.NS — quarterly report dated 2025-03-31
Total revenue: 142978723.4042553
Gross profit: 67564881.92658405
Operating income: 39683189.15127426
Net income: 42446808.5106383
Capital expenditures: 0
Net tangible assets: 1664708908.1131632
Owner earnings: 42446808.5106383
Return on net tangible assets (%): 2.549803650582307
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.507527132687596
P/E ratio: 8.83550688764751
Shares outstanding: 142769679
Book value: 1666958148.2347438
P/B ratio: 0.8999363765708315
Market cap (USD): 1500156275.8175983
Debt to equity: 0.1516926663281708
Current ratio: 6.458640064050333
Quick ratio: 6.279603794840547
Effective tax rate (%): 8.280496122464445
Interest coverage ratio: 6.70187561697927
COGS to revenue (%): 52.744799843014135
Buyback yield (%): 0
Retained earnings: 913459200.3740939
Inventory turnover: 2.5528908939807673
Receivables turnover: 4.892942870859337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0896599231605975
Rule of 40 score: 0
Financial ratios for GESHIP.NS — annual report dated 2025-03-31
Total revenue: 617957680.6172551
Gross profit: 260771568.8566752
Operating income: 215306289.45522562
Net income: 274054243.6287117
Capital expenditures: 20469955.576338552
Operating cash flow: 309487958.84966093
Depreciation & amortization: 95070142.62333411
Net tangible assets: 1664708908.1131632
Owner earnings: 348654430.6757073
Return on net tangible assets (%): 20.94386766217788
Capex to operating income (%): 9.507365357571413
Buffett classification: The Great
Stock price: 10.507527132687596
P/E ratio: 5.473939231716506
Shares outstanding: 142769679
Book value: 1666958148.2347438
P/B ratio: 0.8999363765708315
Market cap (USD): 1500156275.8175983
Debt to equity: 0.1516926663281708
Current ratio: 6.458640064050333
Quick ratio: 6.279603794840547
Effective tax rate (%): 4.770300078401423
Interest coverage ratio: 8.446752889378097
COGS to revenue (%): 57.80106356211962
SG&A to revenue (%): 1.617666254887902
Free cash flow (dilution-adjusted): 172084404.95674536
Buyback yield (%): 0
Retained earnings: 913459200.3740939
Inventory turnover: 12.091376785784954
Receivables turnover: 21.147423587774046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.337720931750088
FCF margin (%): 27.847279895422062
Revenue growth (%): -0.4341682993092651
Rule of 40 score: 27.413111596112795
Financial ratios for GESHIP.NS — quarterly report dated 2025-06-30
Total revenue: 140588579.45237538
Gross profit: 71614790.54528435
Operating income: 50388485.841329284
Net income: 59033465.948981985
Capital expenditures: 0
Owner earnings: 59033465.948981985
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.134799906388956
P/E ratio: 6.732248322240833
Shares outstanding: 142769679
Market cap (USD): 1589711808.3643813
Effective tax rate (%): 5.869841032912904
Interest coverage ratio: 9.597058168041007
COGS to revenue (%): 49.06073393426386
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.6716780615826814
Rule of 40 score: -1.6716780615826814
Financial ratios for GESHIP.NS — quarterly report dated 2025-09-30
Total revenue: 139997745.20856822
Gross profit: 66882750.84554678
Operating income: 48626832.01803833
Net income: 65547914.31792559
Capital expenditures: 0
Net tangible assets: 1714461104.8478014
Owner earnings: 65547914.31792559
Return on net tangible assets (%): 3.823237175377303
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.976888387824125
P/E ratio: 9.382648779336803
Shares outstanding: 142769679
Book value: 1716411499.4363022
P/B ratio: 0.9130484339350798
Market cap (USD): 1567166831.548478
Debt to equity: 0.08235897631263149
Current ratio: 7.597660666498564
Quick ratio: 7.379889540511302
Effective tax rate (%): 3.208030898315243
Interest coverage ratio: 9.88359303391384
COGS to revenue (%): 52.225837104801165
Buyback yield (%): 0
Inventory turnover: 2.4223284652448362
Receivables turnover: 2.8935129089383915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.611915669253431
Revenue growth (%): -0.42025763835768243
Rule of 40 score: -0.42025763835768243
Financial ratios for GESHIP.NS — quarterly report dated 2025-12-31
Total revenue: 162018491.7010137
Gross profit: 85993093.46106717
Operating income: 61859195.72240169
Net income: 90511306.67260778
Capital expenditures: 0
Owner earnings: 90511306.67260778
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.399242508633174
P/E ratio: 6.873648135818994
Shares outstanding: 142769679
Market cap (USD): 1770235872.800713
Effective tax rate (%): 4.018711460769722
Interest coverage ratio: 22.25691382765531
COGS to revenue (%): 46.92390198289375
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 15.729357969043756
Rule of 40 score: 15.729357969043756
Financial ratios for GLAD.V — annual report dated 2022-02-28
Total revenue: 0
Operating income: -451598.4375
Net income: -451598.4375
Capital expenditures: 0
Operating cash flow: -183120.3125
Net tangible assets: 3450104.6875
Owner earnings: -451598.4375
Return on net tangible assets (%): -13.089412594817096
Buffett classification: The Gruesome
Stock price: 0.28125
Shares outstanding: 106076797
Book value: 3450104.6875
P/B ratio: 8.647302577322156
Market cap (USD): 29834099.15625
Debt to equity: 0
Current ratio: 20.372611793865538
Quick ratio: 20.372611793865538
Free cash flow (dilution-adjusted): -399892.1875
Buyback yield (%): 0
Retained earnings: -953229.6875
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.089412594817096
Rule of 40 score: 0
Financial ratios for GLAD.V — annual report dated 2023-02-28
Total revenue: 0
Gross profit: 0
Operating income: -749786.0294117647
Net income: -2583399.264705882
Capital expenditures: 39566.91176470588
Operating cash flow: -675619.1176470588
Depreciation & amortization: 0
Net tangible assets: 1002374.9999999999
Owner earnings: -2622966.176470588
Return on net tangible assets (%): -261.67513919147905
Buffett classification: The Gruesome
Stock price: 0.3455882352941176
Shares outstanding: 106076797
Book value: 1002375
P/B ratio: 36.572034498947346
Market cap (USD): 36658893.08088235
Debt to equity: 0
Current ratio: 4.471488411235059
Quick ratio: 4.471488411235059
Free cash flow (dilution-adjusted): -851858.8235294118
Buyback yield (%): 0
Retained earnings: -3480556.617647059
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -74.80095068330363
Rule of 40 score: 0
Financial ratios for GLAD.V — annual report dated 2024-02-29
Total revenue: 0
Gross profit: -9241.176470588234
Operating income: -5617583.0882352935
Net income: -4678343.382352941
Capital expenditures: 91427.94117647059
Operating cash flow: -4316142.647058823
Depreciation & amortization: 9241.176470588234
Net tangible assets: 4175480.8823529407
Owner earnings: -4760530.147058823
Return on net tangible assets (%): -114.0115421717893
Buffett classification: The Gruesome
Stock price: 0.27941176470588236
Shares outstanding: 106076797
Book value: 4175480.8823529407
P/B ratio: 7.098369236794495
Market cap (USD): 29639105.04411765
Debt to equity: 0
Current ratio: 5.002301222096925
Quick ratio: 5.002301222096925
Free cash flow (dilution-adjusted): -4847089.705882352
Buyback yield (%): 0
Retained earnings: -8158899.999999999
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -124.12749078294144
Rule of 40 score: 0
Financial ratios for GLAD.V — quarterly report dated 2024-11-30
Total revenue: 0
Gross profit: -3056.4285714285716
Operating income: -2314861.4285714286
Net income: -1840649.285714286
Capital expenditures: 0
Operating cash flow: -2258522.142857143
Depreciation & amortization: 3055
Net tangible assets: 4629872.142857143
Owner earnings: -1837594.285714286
Return on net tangible assets (%): -39.68995749805495
Buffett classification: The Gruesome
Stock price: 0.3857142857142858
Shares outstanding: 106076797
Book value: 4629872.142857143
P/B ratio: 8.837249652528204
Market cap (USD): 40915335.985714294
Debt to equity: 0
Current ratio: 14.818478719847986
Quick ratio: 14.818478719847986
Free cash flow (dilution-adjusted): -2555907.8571428573
Buyback yield (%): 0
Retained earnings: -12453372.857142858
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.54495995241465
Rule of 40 score: 0
Financial ratios for GLAD.V — annual report dated 2025-02-28
Total revenue: 0
Gross profit: -14731.25
Operating income: -7258049.305555556
Net income: -5770154.166666667
Capital expenditures: 0
Operating cash flow: -6525257.638888889
Depreciation & amortization: 14731.25
Net tangible assets: 9553181.944444444
Owner earnings: -5755422.916666667
Return on net tangible assets (%): -60.246135268193804
Buffett classification: The Gruesome
Stock price: 0.3194444444444445
Shares outstanding: 106076797
Book value: 9553181.944444444
P/B ratio: 3.547053084843314
Market cap (USD): 33885643.48611111
Debt to equity: 0
Current ratio: 3.081143755704156
Quick ratio: 3.081143755704156
Free cash flow (dilution-adjusted): -7629506.944444444
Buyback yield (%): 0
Retained earnings: -13475781.944444444
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -75.97520227044771
Rule of 40 score: 0
Financial ratios for GLAD.V — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: -5822.916666666667
Operating income: -1481630.5555555555
Net income: -1368336.1111111112
Capital expenditures: 0
Operating cash flow: -802923.6111111111
Depreciation & amortization: 5822.916666666667
Net tangible assets: 9553181.944444444
Owner earnings: -1362513.1944444445
Return on net tangible assets (%): -14.262401808821407
Buffett classification: The Gruesome
Stock price: 0.3194444444444445
Shares outstanding: 106076797
Book value: 9553181.944444444
P/B ratio: 3.547053084843314
Market cap (USD): 33885643.48611111
Debt to equity: 0
Current ratio: 3.081143755704156
Quick ratio: 3.081143755704156
Free cash flow (dilution-adjusted): -1386200.6944444445
Buyback yield (%): 0
Retained earnings: -13475781.944444444
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.509288571826927
Rule of 40 score: 0
Financial ratios for GLAD.V — quarterly report dated 2025-05-31
Total revenue: 0
Gross profit: -8456.521739130436
Operating income: -2737308.6956521743
Net income: -2030299.275362319
Capital expenditures: 86956.52173913045
Operating cash flow: -1820494.2028985508
Depreciation & amortization: 8456.521739130436
Net tangible assets: 8254684.782608696
Owner earnings: -2108799.2753623193
Return on net tangible assets (%): -25.546696583801996
Buffett classification: The Gruesome
Stock price: 0.3695652173913044
Shares outstanding: 106076797
Book value: 8254684.782608696
P/B ratio: 4.749096491978863
Market cap (USD): 39202294.543478265
Debt to equity: 0.009132275787179261
Current ratio: 2.6095954643852775
Quick ratio: 2.6095954643852775
Interest coverage ratio: -3406.2091974752034
Free cash flow (dilution-adjusted): -2193462.31884058
Buyback yield (%): 0
Retained earnings: -16091984.782608697
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.120397540936175
Rule of 40 score: 0
Financial ratios for GLAD.V — quarterly report dated 2025-08-31
Total revenue: 0
Gross profit: -19313.868613138686
Operating income: -5004626.277372262
Net income: -3443637.9562043794
Capital expenditures: 0
Operating cash flow: -4299759.854014598
Depreciation & amortization: 19313.868613138686
Net tangible assets: 5262368.613138686
Owner earnings: -3424324.0875912406
Return on net tangible assets (%): -65.07191607675765
Buffett classification: The Gruesome
Stock price: 0.7007299270072992
Shares outstanding: 106076797
Book value: 5262368.613138687
P/B ratio: 14.12504362263669
Market cap (USD): 74331186.21897809
Debt to equity: 0.011504630384169653
Current ratio: 2.2296759199472254
Quick ratio: 2.2296759199472254
Interest coverage ratio: -2354.5116758241757
Free cash flow (dilution-adjusted): -4665281.02189781
Buyback yield (%): 0
Retained earnings: -19653082.481751822
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -95.10216112335968
Rule of 40 score: 0
Financial ratios for GLAD.V — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: -18900
Operating income: -5540770
Net income: -4089295.7142857146
Capital expenditures: 0
Operating cash flow: -5467613.571428572
Depreciation & amortization: 18900
Net tangible assets: 12743984.285714287
Owner earnings: -4070395.7142857146
Return on net tangible assets (%): -31.939742101287226
Buffett classification: The Gruesome
Stock price: 0.7214285714285715
Shares outstanding: 106076797
Book value: 12743984.285714287
P/B ratio: 6.004937734207143
Market cap (USD): 76526832.12142858
Debt to equity: 0.0034309745472065304
Current ratio: 3.1381398109507512
Quick ratio: 3.1381398109507512
Interest coverage ratio: -3414.206866197183
Free cash flow (dilution-adjusted): -5725833.571428572
Buyback yield (%): 0
Retained earnings: -23261272.85714286
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.47753320922622
Rule of 40 score: 0
Financial ratios for GROV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.35
Shares outstanding: 42028075
Market cap (USD): 2074085501.25
Buyback yield (%): 0.014319563963057717
Capitalized R&D asset: 0
Rule of 40 score: 0